Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00062699
Status:
TERMINATED
Last Update Posted:
2006-08-02
First Post:
2003-06-11
Brief Title:
Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w Stage V Chronic Kidney Disease on Hemodialysis
Sponsor:
Abbott
Organization:
Abbott
Organization Data
Organization:
Abbott
Class:
INDUSTRY
Study ID:
M02-516
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Abbott
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None